Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC N-tert-butyl-3-(acetamido)benzamide | 183619-38-7 | 99.8% | 234.29 g·mol⁻¹ | C13H18N2O2 | 5 MG
Supplier: Medchemexpress LLC HY1003765MG
CPI-1189 is a small-molecule research compound described as an orally active inhibitor of tumor necrosis factor-α (TNF-α) release with reported neuroprotective and anti-inflammatory activity. It inhibits p38 MAPK phosphorylation and is used in preclinical studies of apoptosis, ischemia/reperfusion injury, and neurodegenerative disease models.
- Orally active TNF-α release inhibitor.
- Inhibits phosphorylation of p38 MAPK.
- Reported neuroprotective and anti-inflammatory activity.
- Used in in vitro and in vivo preclinical models of apoptosis and ischemia.
- High purity suitable for research applications.
- Stable as powder at -20°C for long-term storage.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?